Bounty

Zhang Bozhen had indeed run into a major problem. The test results for March Star's first Mutated Animal were out. It could fully serve as Gene Serum Material, and its performance was excellent.

Yet not a single Pharmaceutical Company was willing to purchase it.

The excuse given by these Pharmaceutical Companies was that they already had mature production lines. If they changed raw materials now, they would have to rebuild their production lines.

In truth, these Pharmaceutical Companies wanted to control the source of the raw materials. In other words, they wanted a hand in supplying them.

And their appetite was not small. This would indirectly affect March Star's future development. A planet's development could not be separated from funding.

Of course, the Zhang Family might also be behind this. After all, Peace Technology Company had considerable influence within the Alliance.

It was not as though Zhang Bozhen had not considered giving up part of the profits to the Pharmaceutical Companies.

But aside from the Pharmaceutical Companies, there were also sales channels.

The Alliance had antitrust laws, so Pharmaceutical Companies and sales companies were separate.

These Pharmaceutical Companies participated in Gene Serum bidding projects across different planets.

They could give up benefits to the Pharmaceutical Companies now, but what about the serum sales companies?

Pharmaceutical Companies were not the final link in the chain. There were also the various planets to consider.

Did anyone truly believe that bidding was fair and impartial? Serum sales companies were deeply connected to local forces on every planet.

If March Star wanted to push its serum materials onto the market, it had to satisfy the Pharmaceutical Companies, the serum sales companies, and every local party. Once those benefits were handed out, there would be almost no profit left for the planet itself.

This was,